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neoplasms and involve approximately 30% of all paratesticular masses.
There are several theories about their histogenesis: mesothelial, Müllerian,
mesonephric, and endothelial origin. The mesothelial origin is the most
widely accepted. Adenomatoid tumours usually involve the genitourinary
system in both males and females. Fallopian tubes, ovaries and uterus are
common areas for females, and epididymis, testes, spermatic cord, ejac-
ulatory ducts are common in males. These tumors are usually located in
the tail part of the epididymis usually as a separate mass with a mean age
of presentation between 30 to 40 years. Clinical presentation can vary from
asymptomatic small masses to very painful masses in the scrotum region
which can be confused for torsion. Ultrasonography is the initial investi-
gation of choice with high sensitivity and speciﬁcity rates. Ultrasound
examination demonstrates well circumscribed uniformly hypoechoic
mass, that are usually avascular but may demonstrate internal vascularity
on colour ﬂow Doppler imaging. MRI helps in diagnosis as the lesion ap-
pears hypointense to surrounding parenchyma arising from testicular
surface and enhances less than the normal testis on post contrast
administration. By considering rare benign intratesticular tumors in the
differential diagnosis of testicular masses, normal levels of preoperative
serum tumor markers combined with intraoperative histologic examina-
tion can offer the surgeon to clues of this rare benign tumor. The intra-
operative frozen section should be considered.
NDP005:
TESTICULAR CAPILLARY HEMANGIOMA: CASE REPORT
Yi-Chu Lin, Sheng-Han Tsai, Shin-Shu Chang. Department of Urology, Cheng
Hsin General Hospital, Taipei, Taiwan
Case Presentation: A 17 year-old boy found left testicular mass with
tenderness by himself, and then visited our urology outpatient department
for help. At OPD, physical examination showed a hard nodule in left testis
with tenderness, B-HCG and AFP were normal. Then sonography of
scrotum and CT of abdomen was arrange for further evaluation. Both of
image examinations showed a small hypervascular nodule in lower pole of
left testicle, but no deﬁnite lymphadenopathy or mass in the retroperito-
neal space or inguinal regions were found. For hypervascular tumor of
testis, differential diagnosis included vascular malformation, or germ cell
tumor. As germ cell tumor cannot be rule out, surgical intervention was
suggested. The patient was admitted and operation was arranged on.
During operation, a well circumscribed tumor in left scrotum near
epididymal tail was found, the tumorwas homogenous, brownish and easy
bleeding, tumor size was about 1.5 x1.5 cm, frozen section of tumor was
sent and showed hemangioma with low N/C ratio microscopically.
Therefore, tumor excision with testicle sparing was done according to
frozen section result. The ﬁnal pathology report of the tumor was capillary
hemangioma, which was a benign testicular tumor.
Discussion: Testicular capillary haemangioma is an exceptionally rare
tumor. Capillary haemangioma of the testis can be similar to malignant
testicular tumors on clinical presentation, as well as on ultrasonography
and computed tomography, and therefore should be included in the
intraoperative differential diagnosis. Because of the benign nature of this
lesion, conservative surgical treatment by means of tumor enucleation
with preservation of the testis is possible, if intraoperative examination of
frozen sections of representative tissue can be performed.NDP006:
GNRH AGONIST INDUCED ACUTE FULMINANT HEPATITIS IN PATIENT
WITH PROSTATE CANCER-CASE REPORT
Yu-Cing Juho, Sheng-Tang Wu, Tai-Lung Cha, Guang-Haun Sun, Sun-Yran
Chang, Dah-Shyong Yu. Division of Urology, Departments of Surgery, Tri-
Service General Hospital, National Defense Medical Center, Taipei, Taiwan
An 85 year old man with history of locally advanced prostate cancer
received monotherapy with anti-androgen since 1997. Due to prostate
speciﬁc antigen progression (>500 ng/mL), systemic chemotherapy with
taxotere was performed one year ago. Because of intolerance for chemo-
therapy, the patient went to our outpatient department for secondaryopinion.We then applied complete androgen blockadewith anti-androgen
and GnRH agonist. Three days later, the patient was sent to emergent
department due to poor appetite and conscious disturbance for two days.
History taking revealed no hepatitis B, hepatitis C, drug abuse and alcohol
consumption. Physical examination showed normal vital sign without
scleral icterus. There was no tea color urine or clay stool found. The blood
biochemistry revealed abnormal data with AST 1637 U/L, ALT 3413 U/L and
total bilirubin 0.6 mg/dL. Abdominal sonography at emergent department
found fatty liver without distention of gallbladder. Under the impression of
acute fulminant hepatitis, the patient was admitted for conservative
treatment.
A series of examination was arranged after admission. HAV IgM and HCV
antibody showed negative. Negative of HBV surface antigen with positive
of HBV surface antibody were noted. Other serologic examination revealed
negative ﬁnding of virus infection including CMV, EBV and HSV. Autoim-
mune hepatitis was also excluded by normal range of ANA titer. Other
cause including ischemia, acetaminophen, toxin and alcohol were unlikely
due to lack of evidence.
Under supportive treatment with adequate hydration and silymarin
therapy, the conscious got improved and liver enzyme decreased gradu-
ally. The ﬁnal data of AST/ALT was 597/337 (U/L) one week later after
admission. According the history and serologic examination, this episode
of acute fulminant hepatitis might be induced by GnRH agonist.
Conclusion: GnRH agonist is used as hormone therapy for controlling
prostate cancer with anti-androgen. However, drug toxicity induced acute
fulminant hepatitis was observed in this case. We should pay more
attention for symptom and liver function in patients who received GnRH
agonist therapy.
NDP007:
PARATESTICULAR DEDIFFERENTIATED LIPOSARCOMAdA CASE REPORT
You-Chiuan Chien, Chun-Chi Chen, Bai-fu Wang, Kuo-Chin Wei. Divisions
of Urology, Department of Surgery, Changhua Christian Hospital, Changhua,
Taiwan
Background: Paratesticular liposarcomas are rare tumors which account
for 12% of all liposarcomas. They must be differentiated from tumors of
testicular origin which have extension to the spermatic cord.
Clinical Case: We reported a case of a 72-year-old male who had pre-
sented with a painless swelling mass in the left hemiscrotum, which
was of 10 years' duration. Initially, a clinical impression of scrotal tumor
was made; however, CT of the scrotum revealed a spermatic cord mass.
The mass was managed by excisional biopsy and later pathology re-
ported dedifferentiated liposarcoma with margin involvement. Meta-
static work-up, which included CT of the abdomen and pelvis and chest
X ray, did not reveal any distant metastasis. Patient underwent high
orchidectomy with skin excision. Histopathological studies conﬁrmed
the diagnosis of dedifferentiated liposarcoma with clear surgical
margin.
Conclusion: Liposarcomas of the spermatic cord represent a rare type of
tumors, which are often misdiagnosed preoperatively. Being a rare disease
and varied type of presentation, paratesticular liposarcoma should be
considered as a possibility during the differential diagnosis of fat con-
taining inguino-scrotal mass.NDP008:
TUMOR MARKER OREINTATED CHEMOTHERAPY IN CANCER OF
UNKNOWN PRIMARY SITE: A CASE REPORT AND LITERATURE REVIEW
Yu-De Wang, Chao-Hsiang Chang, Chi-Rei Yang. Department of Urology,
China Medical University Hospital, Taichung, Taiwan
A case of a 56-year-old woman, who presented with acute abdomen, was
diagnosed retroperitoneal poorly differentiated carcinoma of unknown
primary site without ovarian involvement. We encountered failure
attempt of tumor excision initially. In spite of a primary lesion was not
conﬁrmed, we performed tumor maker (CA-199) orientated chemo-
therapy with the regimen of carboplatin and paclitaxel according to tumor
markers and pathological ﬁndings.
Abstracts / Urological Science 26 (2015) S50eS81S52The size of main tumor decreased remarkably, and retroperitoneal
dissection was done successfully after then. Most patients with cancer of
unknown primary origin have a very poor prognosis because it is difﬁcult
to select appropriate treatment. Tumor marker provide not only as a tool
for monitoring but also a guide for chemotherapy regiment. Tumor marker
orientated chemotherapy makes operation more feasible and achieves
better diagnosis and treatment, as in the case describe here.
NDP009:
FUNCTIONAL ADRENAL ONCOCYTOMA (INCIDENTALOMA): A CASE
REPORT
Tsu-Feng Lin MD, Ding-Po Lin MD, Marcelo Chen MD, Jong-Ming Hsu MD.
Purpose: Oncocytic neoplasms are most commonly found in the kidney,
thyroid and salivary gland. Adrenal oncocytomas are very rare. There is
female predominance with a mean age of 46 years. These tumors are more
common on the left side (1:2). Most of these tumors are nonfunctional and
hence incidentally detected. Here, we report a case of functional adrenal
oncocytoma.
Case report: A 54-year-old female had past history of Type 2 Diabetes
mellitus and Hypertension undermedication control for ten years. She
felt gerneral weakness and abdominal discomforts for half year. There
were no palpitations, headache, weakness or fatigue, and the physical
examination was unremarkable. So she came to our Gastroenterology
outpatient department for further survey. Abdominal echo showed a
mixed hypoechoic lesion about 5cm at S6-7. The tumor has well margin,
echoic ring at the periphery without vascular invasion. Abdominal
computed tomography scan was performed after then and it showed a
right adrenal mass (6.3x4.8cm in size) with punctate calciﬁcation and
heterogeneous enhancement. 48 hours low dose dexamethasone sup-
pression test was arranged, and it showed positive. (base line: Cortisol/
ACTH: 20.16mg/dL /6.53pg/mL, post dexa: 18.88mg/dL /1.17 pg/mL). Other
Hemogram and serum biochemistry were within normal limits, except
polycythemia (hemoglobin: 17.7g/dl) that was same as before. The
tentative diagnosis is right adrenal incidentaloma with Cushing syn-
drome. She underwent laparoscopic adrenalectomy. The pathologic
report showed a well-encapsulated oncocytoma composed of nesting
and trabeculae polygonal cells with abundant granular, eosinophilic
cytoplasm. After sugery, she received regular OPD follow up in our hos-
pital without any complication.
Conclusion: Adrenal oncocytic neoplasm is usually a large, benign,
nonfunctional adrenal tumor and is found incidentally. Only 17% functional
adrenal mass (Cushing, pheochromocytoma, virilizing syndrome). The
mainstay of therapy is adrenalectomy, recently performed by laparoscopy.
The prognosis is good for benign tumors.
NDP010:
SYNCHRONOUS IPSILATERAL RENAL CELL CARCINOMA AND URO
THELIAL CARCINOMA OF KIDNEY OR URETER: CASES REPORT AND
LITERATURE REVIEW
Yu-Cheng Chang 1,2, Chia-Cheng Yu 1,2, Tony T. Wu 1,2. 1Division of Urology,
Kaohsiung Municipal Min-Sheng Hospital, Taiwan; 2Division of Urology,
Department of Surgery, Kaohsiung Veterans General Hospital, Taiwan
Purpose: We report 2 cases (a 63-year-old female and a 60-year-old fe-
male) were diagnosed of i Simultaneously ipsilateral urothelial carcinoma
(UC) of upper urinary tract and renal Cell carcinoma (RCC) had the
symptoms of painless gross hematuria and conﬁrmed by pathological
document.
Materials and Methods: In case 1 : The abdominal computed tomography
(CT) scan was described as left upper third ureter tumor with extension to
renal pelvis, measured about 4 cm in size, with post-contrast enhance-
ment, urothelial cancer was considered. In case 2 : The abdominal
computed tomography (CT) scan found a suspicious focal enhanced area is
noted in right kidney, 1.5 cm, RCC cannot be excluded, the ﬁndings should
be differentiated with inﬁltrated TCC in calyx.
Results: In case 1 : She received the operation of anterior exenteration and
the pathology showed urothelial carcinoma of left U/3 Ureter and clear cell
type renal cell carcinoma. In case 2 : She received rightnephroureterectomy with bladder cuff excision for urothelial carcinoma of
renal pelvis and unclassiﬁed renal cell carcinoma.
Conclusion: The most symptoms of the synchronous RCC and UC are ﬂank
pain and gross hematuria. Synchronous RCC and UC of the same kidney is a
rare condition and surgical intervention of radical nephroureterectomy
with bladder cuff excision may be a curative treatment for clinically
localized tumor.
NDP011:
RENAL CELL CARCINOMA WITH SYNCHRONOUS CONTRALATERAL
URETERIC METASTASIS e A CASE REPORT AND LITERATURE REVIEW
Kun-Lin Hsieh 1, Wei-Hong Lai 1, Steven Kuan-Hua Huan 2. 1Division of
Urology, Department of Surgery, Chi Mei Medical Center, Taiwan; 2Division
of Uro-Oncology, Department of Surgery, Chi Mei Medical Center, Taiwan
Purpose:When treating the renal cell carcinoma (RCC), preservation of renal
function is important as cancer control. Besides, metastasis of renal cell
carcinoma (RCC) to ureter is extremely rare. In our review, total 54 cases had
been reported about RCCwithuretericmetastasis and just only 11 patients of
them developed contralateral ureteric metastasis. We here presented RCC
with synchronous contralateral ureteric metastasis and our management to
this patient. We also reviewed the associated literature in this report.
Materials and Methods: A 61-year-old healthy man suffered from inter-
mittent painless hematuria for two months. He visited other hospital
ﬁrstly, where intravenous pyelography revealed obstructive lesion over
right ureter. He then went to our outpatient department for second
opinion. Impaired renal function with serum creatinine (Cr) showed
1.63 mg/dL and glomerular ﬁltration rate (GFR) calculated 34 ml/min.
Abdominal computed tomography (CT) revealed right upper-third ureter
tumor with moderate hydronephrosis. Besides, a tumor about 3cm at left
kidney was also detected, which favor RCC. Thus, the diagnosis ureter-
orenoscopy (URS) was performed, and pathology from endoscopic biopsy
to right ureter tumor presented with metastasis RCC.
Considering about preservation of renal function as well as principle of
RCC management, we performed the cytoreductive nephrectomy with
metastasectomy for him. Laparoscopic partial nephrectomy to left RCC and
segmental resection of right ureter with ureteroureterostomy was done.
The target therapy, Sunitinib, is also prescribed for the metastatic status of
RCC. He recovered well and no tumor progression found during six months
follow up till now. Image showed no dilatation of right pyelocalyceal
system, and postoperative renal function is preserved as Cr: 1.67 mg/dL at
3-month-later follow up.
Results: It is reported that approximately one third of patients with RCC
present with metastases. Several atypical presentations and rare meta-
static sites had been reviewed in the literature.1 RCC with ureteric
metastasis is very rare and just about 54 cases had been reported.2 Due to
only 4 cases had been reported of RCC presented as synchronous contra-
lateral ureteric metastasis, there is no consensus as to the most appro-
priate management.
Cytoreductive nephrectomy and surgical metastasectomy has been shown
to improve survival beneﬁt.3 It had been recommend as principle of
management metastasis RCC.4 Our patient has favorable outcome
including not only tumor prognosis but also renal function.
Besides, we also learned from this case that detailed evaluation to patient
with suspect ureter lesion is very important. Awareness of thesemetastatic
tumors could lead to early detection and improvement in management.5
Conclusion: In our review, this is the 5th case presented as RCC with
synchronous contralateral ureteric metastasis. Partial nephrectomy with
segmental resection of contralateral ureter seems effective as surgical
treatment. It had satisﬁed outcome in not only prognosis of cancer but also
renal function.
NDP012:
NEPHROGENIC ADENOMA OF URETER e CASE REPORT
Chin Wei Kuo, Meng-Yi Yan, Bai-Fu Wang. Divisions of Urology, Department
of Surgery, Changhua Christian Hospital, Changhua, Taiwan
Purpose: Nephrogenic adenoma is a rare benign lesion of urothelium. It is
usually occurred in urinary bladder. And in ureter, the recorded cases are
